Zentek Ltd (formerly known as ZEN Graphene Solutions and before that, Zenyatta Ventures) is a mineral exploration and development company based in Ontario, Canada. Zentek is developing the Albany Graphite Deposit – a rare hydrothermal graphite deposit with the potential to produce a natural, high-purity graphite that may compete in high-technology markets traditionally reserved for synthetic graphite.
The company's high crystallinity graphite can be upgraded without the use of aggressive acid (HF) or high temperature thermal treatment. Zentek has developed an environmentally friendly metallurgical process flowsheet that consists of grinding, flotation and caustic treatment using sodium hydroxide. The company states that it has been able to achieve an extraordinary carbon purity result of >99.9 percent in bench-scale tests, using this proprietary and environmentally friendly purification process.
According to Zentek, current end uses for its graphene materials include composites (concrete, rubber and plastics), energy storage and environmental applications but many more are under development.
1224 Amber Drive
Thunder Bay ON P7B 6M5
Canada
Zentek provides market update on ZenGUARD antimicrobial surgical masks
Zentek has provided an update on recent commercialization activities for its ZenGUARD™ Antimicrobial Surgical Masks.
As previously announced in July 2024, the Company embarked on a Canada-wide sampling program for dental professionals facilitated by Henry Schein Inc. that saw ZenGUARD™ Antimicrobial Surgical Masks included in product shipments to Henry Schein customers across Canada. As a result of this program, the Company is now reportedly seeing increased demand from Henry Schein, the world’s largest provider of health care solutions to office-based dental and medical practitioners with a presence in 33 countries.
Zentek announces closing of non-brokered private placement of units
Zentek has announced that it has closed its non-brokered private placement for gross proceeds of CAD$3,069,950 (around USD$2,254,000). Net proceeds of the Offering will be used for working capital and general corporate purposes.
Zentek's CEO, Greg Fenton, commented: "We would like to thank all those who participated in the Offering. This funding will allow us to immediately allocate resources to our international market expansion strategy, where ZenGUARD-coated HVAC filters can play a meaningful role in an entity's sustainability objectives."
Zentek reports earnings for the first quarter ended June 30, 2024
Zentek has reported its earnings for the first quarter ended June 30, 2024. For the first quarter, the Company reported sales was CAD 0.005489 million (USD$0.004). Net loss was CAD 2.55 million (around USD$1,857,000) compared to CAD 3.16 million (around USD$2,300,000) a year ago.
Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.03 a year ago. Diluted loss per share from continuing operations was CAD 0.03 compared to CAD 0.03 a year ago.
Zentek launches sampling program for ZenGUARD™ Antimicrobial Surgical Masks across Canada
Zentek has announced that it will embark on a Canada-wide sampling program for dental professionals facilitated by Henry Schein that will see ZenGUARD™ Antimicrobial Surgical Masks included in product shipments to Henry Schein customers.
In addition to offering dental practitioners and their patients a surgical mask with improved protection against infectious agents, ZenGUARD™ Antimicrobial Surgical Masks are also said to be proven to eliminate 99.9% of bacteria, which can collect on the skin when wearing a surgical mask for extended periods and cause acne. The Company believes this program will introduce ZenGUARD™ Antimicrobial Surgical Masks and this unique value proposition to nearly all Henry Schein customers across Canada.
Zentek announces non-brokered private placement of units for over USD$2 million
Zentek has announced its intention to complete a non-brokered private placement of up to CAD$3 million (around USD$2,180,000). Gross proceeds of the offering will be used for working capital and general corporate purposes.
In May 2024, Zentek received a patent by the Canadian Intellectual Property Office, titled: Graphene Oxide-Cationic Silver (GO-Ag+) Nanocomposites and Their Use as a Broad-Spectrum Antimicrobial Agent. In December 2023, Zentek announced the launch of Triera Biosciences as its wholly owned subsidiary for its aptamer platform technology. Then, in May 2024, Zentek and Triera Biosciences announced achieving positive results against Avian Influenza (H5N1) using their Multivalent Aptamer Technology.
Zentek launches Triera Biosciences
Canada-based Zentek has announced the launch of Triera Biosciences as its wholly owned subsidiary for its aptamer platform technology. This subsidiary now owns the exclusive, global licensing rights for all aptamer-based technology from the collaboration with McMaster University.
The Company is repotedly taking this action following the strong, consistent pre-clinical results of its universal aptamer as a treatment against the SARS-CoV-2 virus including the latest Omicron XBB 1.5 variant and will continue to build upon its previous work on a rapid detection platform within the new subsidiary. Triera will offer a pure play in the biotech space when operated as an independent business and be more accessible to potential pharmaceutical partners, funders, and other interested parties.
Zentek announces R&D contract to test ZenARMOR nano-pigments in corrosion protection aerospace paint systems
Zentek recently announced a new research and development contract through Innovative Solutions Canada to test ZenARMOR™ nano-pigment in military grade, chromate-free, corrosion protection aerospace paint systems.
The testing will be conducted under the supervision of Dr. Qi Yang, and Dr. Naiheng Song, Research Officers at the National Research Council of Canada (NRC) Aerospace Research Centre’s Aerospace Manufacturing Technologies Centre (AMTC).
Zentek and Pattern Energy to collaborate on icephobic technology for wind turbine industry
Zentek has announced a collaboration with Pattern Energy Group to optimize, test and validate Zentek’s icephobic coating for the wind turbine industry. The partnership is being supported financially by both the Natural Sciences and Engineering Research Council of Canada (“NSERC”) and PRIMA Quebec - Advanced Materials Moving Forward.
Pattern Energy develops, constructs, owns, and operates wind turbines and understands the lost efficiency and potential damage to the wind turbine itself and its surroundings that comes from ice accretion on these structures.
Zentek updates on graphene-based icephobic technology for drones
Following its September 2022 announcement on testing of icephobic coating technology, Zentek has now reported successful drone testing, where thrust was maintained under calibrated icing conditions of freezing drizzle and freezing rain in an outdoor, real-world environment. The drone with Zentek's icephobic coating applied to the propeller blades hovered under the outdoor icing rig and, on all tests conducted, maintained flight until the end of the battery life of the drone. The same drone with uncoated propeller blades rapidly lost the ability to maintain flight, according to the Company.
Zentek shared that the coating is a functionalized graphene oxide augmented elastomer.
Zentek announces new project for graphene-enhanced battery components for the automotive industry
Zentek recently announced the start of a 4-year, CAD$1,600,000 (around USD$1,172,000) research project in collaboration with Professors Mohini Sain and Ning Yan from the University of Toronto (“U of T”) and Ford Powertrain Engineering Research and Development Centre (“PERDC”).
Funding for the project includes CAD$1.2 million (around USD$879,000) from the Mitacs Accelerate program. Prof. Sain is the Endowed Ford Motor Canada Chair in Sustainable Materials where he is active in the field of light energy storage including cell chemistry and renewable fuel battery development at PERDC, and Prof. Yan is the Tier 1 Canada Research Chair in Sustainable Bioproducts. Collaborating with the PERDC and testing at this facility is essential to demonstrate battery advances at a scale suitable for the automotive industry.
Pagination
- Page 1
- Next page